Sandborn, William J.

STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD

Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., et al. (2021) · Gastroenterology

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 2,911

The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study

Faubion, W. A., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2001) · Gastroenterology

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 1,144

A gp130–Src–YAP module links inflammation to epithelial regeneration

Taniguchi, K., Wu, L.-W., Grivennikov, S. I., de Jong, P. R., Lian, I., Yu, F.-X., Wang, K., Ho, S. B., Boland, B. S., Chang, J. T., et al. (2015) · Nature

Cytokine Signaling Pathways and InteractionsHippo pathway signaling and YAP/TAZ

Cited by 633

Crohn's disease in Olmsted County, Minnesota, 1940–1993: Incidence, prevalence, and survival

Loftus, E. V., Silverstein, M. D., Sandborn, W. J., Tremaine, W. J., Harmsen, W. S., & Zinsmeister, A. R. (1998) · Gastroenterology

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 623

Global chemical effects of the microbiome include new bile-acid conjugations

Quinn, R. A., Melnik, A. V., Vrbanac, A., Fu, T., Patras, K. A., Christy, M. P., Bodai, Z., Belda-Ferre, P., Tripathi, A., Chung, L. K., et al. (2020) · Nature

Gut microbiota and healthMetabolomics and Mass Spectrometry Studies

Cited by 579

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

Feagan, B. G., Sandborn, W. J., D'Haens, G., Panés, J., Kaser, A., Ferrante, M., Louis, E., Franchimont, D., Dewit, O., Seidler, U., et al. (2017) · The Lancet

Inflammatory Bowel DiseasePsoriasis: Treatment and Pathogenesis

Cited by 451

Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity

Mills, R. H., Dulai, P. S., Vázquez-Baeza, Y., Sauceda, C., Daniel, N., Gerner, R. R., Batachari, L. E., Malfavon, M., Zhu, Q., Weldon, K., et al. (2022) · Nature Microbiology

Gut microbiota and healthInflammatory Bowel Disease

Cited by 385

Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease

Sandborn, W. J., Feagan, B. G., Loftus, E. V., Peyrin-Biroulet, L., Van Assche, G., D’Haens, G., Schreiber, S., Colombel, J.-F., Lewis, J. D., Ghosh, S., et al. (2020) · Gastroenterology

Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies

Cited by 322

Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease

Williet, N., Sandborn, W. J., & Peyrin–Biroulet, L. (2014) · Clinical Gastroenterology and Hepatology

Inflammatory Bowel DiseaseHealth Systems, Economic Evaluations, Quality of Life

Cited by 260

American Gastroenterological Association Consensus Development Conference on the Use of Biologics in the Treatment of Inflammatory Bowel Disease, June 21–23, 2006

Clark, M., Colombel, J.-F., Feagan, B. C., Fedorak, R. N., Hanauer, S. B., Kamm, M. A., Mayer, L., Regueiro, C., Rutgeerts, P., Sandborn, W. J., et al. (2007) · Gastroenterology

Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies

Cited by 224

Converging goals of treatment of inflammatory bowel disease from clinical trials and practice

Levesque, B. G., Sandborn, W. J., Ruel, J., Feagan, B. G., Sands, B. E., & Colombel, J.-F. (2015) · Gastroenterology

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 217

A Population-based Study of Incidence, Risk Factors, Clinical Spectrum, and Outcomes of Ischemic Colitis

Yadav, S., Dave, M., Edakkanambeth Varayil, J., Harmsen, W. S., Tremaine, W. J., Zinsmeister, A. R., Sweetser, S. R., Melton, L. J., Sandborn, W. J., & Loftus, E. V. (2015) · Clinical Gastroenterology and Hepatology

Abdominal vascular conditions and treatmentsAortic Thrombus and Embolism

Cited by 164

Incidence, risk factors, and outcomes of colorectal cancer in patients with ulcerative colitis with low-grade dysplasia: a systematic review and meta-analysis

Fumery, M., Dulai, P. S., Gupta, S., Prokop, L. J., Ramamoorthy, S., Sandborn, W. J., & Singh, S. (2017) · Clinical Gastroenterology and Hepatology

Inflammatory Bowel DiseaseColorectal Cancer Screening and Detection

Cited by 161

Short CDAI: Development and validation of a shortened and simplified Crohnʼs disease activity index

Thia, K., Faubion, W. A., Loftus, E. V., Persson, T., Persson, A., & Sandborn, W. J. (2011) · Inflammatory Bowel Diseases

Inflammatory Bowel DiseaseHealth Systems, Economic Evaluations, Quality of Life

Cited by 134

An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials

Ma, C., Sedano, R., Almradi, A., Vande Casteele, N., Parker, C. E., Guizzetti, L., Schaeffer, D. F., Riddell, R. H., Pai, R. K., Battat, R., et al. (2021) · Gastroenterology

Inflammatory Bowel DiseaseMicroscopic Colitis

Cited by 105

An expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials

Almradi, A., Ma, C., D'Haens, G. R., Sandborn, W. J., Parker, C. E., Guizzetti, L., Borralho Nunes, P., De Hertogh, G., Feakins, R. M., Khanna, R., et al. (2021) · Alimentary Pharmacology & Therapeutics

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 34

Do Not Assume Symptoms Indicate Failure of Anti–Tumor Necrosis Factor Therapy in Crohn's Disease

Bruining, D. H., & Sandborn, W. J. (2011) · Clinical Gastroenterology and Hepatology

Inflammatory Bowel DiseaseRheumatoid Arthritis Research and Therapies

Cited by 20

A Framework for Clinical Trials of Neurobiological Interventions That Target the Gut-Brain Axis in Inflammatory Bowel Disease

Tse, C. S., Singh, S., & Sandborn, W. J. (2022) · Inflammatory Bowel Diseases

Inflammatory Bowel DiseaseStatistical Methods in Clinical Trials

Cited by 3